3M™ Kerracel™ Ag Gelling Fiber Dressing, CWL1183, 2 cm x 46 cm, 5/Ct, 10 Cts/Cs

This dressing is the only gelling dressing with Ag OXYSALTS™ Technology (Ag³⁺), providing up to 6 times more power than traditional silvers (Ag¹⁺) *¹:

• Kills bacteria within a biofilm and prevents biofilm re-formation*,²
• Quickly kills at least 99.999% (5 log) of a broad spectrum of bacteria^*,3,4

A proven substrate, this dressing is a carboxymethyl cellulose (CMC) gelling fiber dressing designed to help create the optimal healing environment*:

• Quickly absorbs and locks away exudate and its harmful components^5,6
• Micro-contours to the wound bed to eliminate dead space where bacteria can live⁷
• Designed to reduce the risk of periwound maceration⁶
• Strong enough to be removed in one piece⁸

*As demonstrated in vitro

¹ Spina C. Silver I, II, III: Chemical characteristics, properties, and anti-microbial activity. Crawford Healthcare Ltd.
² Evaluation of antimicrobial activity of KERRACEL™ Ag and Aquacel® Ag Extra™ against in vitro biofilms. CHC R541. 2017. Crawford Healthcare Ltd.
³ Antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against planktonic species over 7 days in vitro. CHC R539. 2017. Crawford Healthcare Ltd.
⁴ Rate of antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against S. aureus and P. aeruginosa in vitro. CHC R540. 2017. Crawford Healthcare Ltd.
⁵ Evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ sequester bacteria. CHC R543. 2017. Crawford Healthcare Ltd.
⁶ In vitro fluid handling properties of KERRACEL™ Ag and Aquacel® Ag Extra™. CHC R545. 2017. Crawford Healthcare Ltd.
⁷ Zone of inhibition evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ to uniformly kill planktonic bacteria. CHC R544. 2017. Crawford Healthcare Ltd.
⁸ An assessment of silver ribbon dressings using a porcine cavity model. CHC R530. 2017. Crawford Healthcare Ltd.

Ag OXYSALTS™ Technology is a trademark of Argent Limited Partnership